Generic placeholder image

Recent Patents on CNS Drug Discovery (Discontinued)

Editor-in-Chief

ISSN (Print): 1574-8898
ISSN (Online): 2212-3954

Translating Genetic Findings into Therapy in Parkinson Disease

Author(s): Sagrario M. Palomo and Adriano Jimenez-Escrig

Volume 2, Issue 3, 2007

Page: [229 - 237] Pages: 9

DOI: 10.2174/157488907782411747

Price: $65

Abstract

In the last decade, current opinion for Parkinson disease (PD) etiology has swung from the hypothesis of a toxic/environmental disorder to understanding it as a highly heritable condition. Recent research conducted in families affected from PD has disclosed 6 genes that codify for proteins in pathways of neurodegeneration in PD. This review focuses in new drugs aimed to prevent the apparition and progression of the disease developed after the knowledge obtained from the genetic studies of PD, covering most recent and important patents.

Keywords: Synuclein, parkin, LRRK2, proteasome


Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy